Resultados de la búsqueda 351-360 de 3103 para anti-TNF drugs
Participants in this study will either have heart failure (HF) and are scheduled to undergo cardiac resynchronization therapy pacemaker (CRT-P) or cardiac ...
ADPKD is a leading cause of end-stage renal disease. Recently, a new medication called Tolvaptan has been approved by the FDA to slow progression of ADPKD.
Patients in cohorts 1.11 and 1.12 (currently lacking detectable cancer) will undergo the collection at least 4 weeks after conclusion of therapy. In addition to ...
The purpose of this study is to evaluate the effect of immunotherapy drugs (ipilimumab and nivolumab) in treating patients with glioblastoma that has come back ...
https://www.arthritis.org/drug-guide/medication-topics/topical-nsaids-offer-joint-pain-relief. Accessed April 17, 2023. Deveza LA, et al. Management of knee ...
Cancer terms: Treatment. ASCO Cancer.Net. https://www.cancer.net/navigating-cancer-care/cancer-basics/cancer-terms-treatment. Accessed. March 14, 2018 ...
The purpose of ths study is to find out more about the side effects of two new drug combinations for lymphoma, TTI-621 and pembrolizumab and TTI-622 and ...
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina? Para ...
... treatment response to targeted therapy and immunotherapy for patients who ... therapy medication as prescribed (medication adherence). Metastatic Tumor ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?